WHO ICTRP trial
Randomized controlled study of standard channel PCNL versus enhanced ultramicro…
ChiCTR2100045095 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100045095 |
|---|---|
| Public title | Randomized controlled study of standard channel PCNL versus enhanced ultramicro channel percutaneous nephrolithotomy (ESMP) for treatment of renal calculi (>=3cm) |
| Scientific title | Randomized controlled study of standard channel PCNL versus enhanced ultramicro channel percutaneous nephrolithotomy (ESMP) for treatment of renal calculi (>=3cm) |
| Primary sponsor | People's Hospital of Xinjiang Uygur Autonomous Region |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Kidney stones (>=3CM) |
| Interventions | experimental group:Standard channel PCNL;control group:Enhanced ultramicrochannel percutaneous nephrolithotomy (ESMP) |
| Registration date | Apr 6, 2021 |
| Target size | experimental group:50;control group:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: